Mallinckrodt Must Face Infant Drug Pricing Claims
A New Jersey federal judge ruled Tuesday that Mallinckrodt will have to face claims in a proposed class action alleging the company violated antitrust laws by scheming to artificially and "dramatically"...To view the full article, register now.
Already a subscriber? Click here to view full article